Niveau de preuve du suivi thérapeutique pharmacologique de la ceftriaxone-Reference-Cited by-同舟云学术

Niveau de preuve du suivi thérapeutique pharmacologique de la ceftriaxone

Published:2012-03 Issue:2 Volume:67 Page:145-149
ISSN:0040-5957
Container-title:Therapies
language:fr
Short-container-title:Therapies

Author:

Dailly Eric,Verdier Marie-Clémence,Deslandes Guillaume,Bouquié Régis,Tribut Olivier,Bentué-Ferrer Danièle

Publisher

Elsevier BV

Subject

Pharmacology (medical)

Reference41 articles.

1. Résumé des caractéristiques du produit de la ceftriaxone (Rocéphine©) 1984 rév 02.05.2007 – Vidal.

2. Management of acute community-acquired bacterial meningitides, except in newborn infants. Short text. November 2008;Société de pathologie infectieuse de langue française Rev Neurol (Paris),2009

3. Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept;Roberts;Int J Antimicrob Agents,2010

4. Méthodologie pour l’évaluation du niveau de preuve du suivi thérapeutique pharmacologique;Le Guellec;La Lettre du Pharmacologue,2009

5. Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration;Borner;Chemotherapy,1985

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liver function, quantified by the LiMAx test, as a predictor for the clinical outcome of critically ill patients treated with linezolid;Technology and Health Care;2021-06-25

2. Tolerability of high-dose ceftriaxone in CNS infections: a prospective multicentre cohort study;Journal of Antimicrobial Chemotherapy;2019-01-29

3. Prolonged ceftriaxone-induced immune thrombocytopenia due to impaired drug clearance: a case report;TRANSFUSION;2013

4. Antibiotic Resistance of Gram-Negative Bacilli Isolated from Pediatric Patients with Nosocomial Bloodstream Infections in a Mexican Tertiary Care Hospital;Chemotherapy;2013